US 11129841
CD73 inhibitors
granted A61KA61K31/675A61K31/7064
Quick answer
US patent 11129841 (CD73 inhibitors) held by ORIC PHARMACEUTICALS, INC. expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ORIC PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/675, A61K31/7064, A61K45/06, A61P